Hungarian medicine budget plans reviewed by BMI

A new report, titled Hungary Pharmaceuticals and Healthcare Report Q4 2011 from Business Monitor International continues to project that the Hungary’s Szell Kalman structural reforms plan, which aims to achieve savings of 120 billion forint ($580 million) over three years from the nation’s medicine budget will lead to year-on-year contractions in 2012 and 2013. However, the research stresses that the 30% contraction in public reimbursement funding will not lead to an equivalent contraction of drug market expenditure.

BMI notes that the method the government will employ to achieve these savings have yet to be revealed, creating considerable complexity in the forecast scenario, although the report expects fresh details to be prepared by the authorities by the end of September 2011.

Headline expenditure projections